AG0036DQ

84057-84-1 | 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine

Chemical structure of 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine, CAS 84057-84-1
AG0036DQ
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 84057-84-1
Catalog Number AG0036DQ(AGN-PC-04XSOH)
Chemical Name 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine
EC Number 281-901-8
IUPAC Name 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
InChI InChI=1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)
InChI Key PYZRQGJRPPTADH-UHFFFAOYSA-N
MDL Number MFCD00865333
Molecular Formula C9H7Cl2N5
Molecular Weight 256.0914
SMILES ClC1=C(C=CC=C1Cl)C1=C(N=C(N=N1)N)N
UNII U3H27498KS
Synonyms
3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine, 3,5-diamino-6-(2,3-dichlorophenyl)-as-triazine, BW 430C, BW-430C, BW430C, Crisomet, Labileno, Lamictal, Lamiktal, lamotrigine, lamotrigine, 84057-84-1, 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine, Lamictal, Lamictal Cd, Lamotrigina, Lamotriginum, Lamictal XR, Lamotriginum [Latin], Lamotrigina [Spanish], BW-430C, Lamictal ODT, BW 430C, 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine, 1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)-, 3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine, UNII-U3H27498KS, EINECS 281-901-8, MFCD00865333, CHEMBL741, C9H7Cl2N5, GW 273293, MLS000069685, CHEBI:6367, PYZRQGJRPPTADH-UHFFFAOYSA-N, U3H27498KS, Lamotrigine, 98%, NCGC00015605-06, Labileno, Lamiktal, Lamitor, SMR000058464, DSSTox_CID_3195, DSSTox_RID_76918, DSSTox_GSID_23195, Lamictin, Lamictal (TN), CAS-84057-84-1, Lamotrigine [USAN:INN:BAN], BW430C, SR-01000000187, Lamotrigine (JAN/USAN/INN), HSDB 7526, EUR-1048, Lamotrigine [USAN:USP:INN:BAN], zine-3,5-diamine, GI 267119X, Opera_ID_12, Tocris-1611, hydroxymethyl progesterone, AC1L1GWT, Lopac-L-3791, L 3791, Lopac0_000688, SCHEMBL35439, MLS000759486, MLS001077325, MLS001423991, BIDD:GT0794, Lamotrigine, >=98%, powder, GTPL2622, TRI020, DTXSID2023195, CTK8B4406, KS-00000XIV, ZINC13156, HMS2051C10, HMS2089M08, HMS2093P21, HMS2230L04, HMS3262I17, HMS3268G17, HMS3371O16, HMS3393C10, HMS3657A17, HMS3715H21, Pharmakon1600-01505610, BCP12156, HY-B0495, Lamotrigine 1.0 mg/ml in Methanol, Tox21_110179, Tox21_500688, ANW-44921, BDBM50031299, NSC746307, NSC759171, s3024, STK628377, AKOS005561147, Tox21_110179_1, 6-(2,2,4-triazine-3,5-diyldiamine, CCG-100856, CS-2616, DB00555, KS-1074, LP00688, MCULE-7648410888, NC00106, NE61394, NSC-746307, NSC-759171, SMP2_000303, NCGC00015605-01, NCGC00015605-02, NCGC00015605-03, NCGC00015605-04, NCGC00015605-05, NCGC00015605-07, NCGC00015605-08, NCGC00015605-09, NCGC00015605-10, NCGC00022936-02, NCGC00022936-04, NCGC00022936-05, NCGC00261373-01, AC-10298, AJ-08354, AK-72807, AN-35947, AT-15488, BC200572, BR-72807, CPD000058464, K499, SAM001246697, SC-12025, SBI-0050666.P002, 6-(2,3-Dichloro-phenyl)-[1,2,4]tria, AB0014255, LS-155249, TR-026049, B2249, EU-0100688, FT-0602546, L-205, L0241, ST24024203, SW197486-3, 57L841, A11873, D00354, J10032, AB00384359-16, AB00384359_17, AB00384359_18, A840709, 3,5-diamino-(2,3-dichlorophenyl)-1,2,4-triazine, 3,5-diamino-6-(2,3-dichlorophenyl)- as -triazine, Q-201221, SR-01000000187-2, SR-01000000187-4, SR-01000000187-7, BRD-K93460210-071-01-6, SR-01000000187-10, 3,5-diamino-6-(2,3,-dichlorophenyl)-1,2,4-triazine, 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine., F2173-0540, Z1550648755, 6-(2,3-Dichloro-phenyl)-[1,2,4]triazine-3,5-diamine, 6-[2,3-bis(chloranyl)phenyl]-1,2,4-triazine-3,5-diamine, Lamotrigine, British Pharmacopoeia (BP) Reference Standard, Lamotrigine, European Pharmacopoeia (EP) Reference Standard, 6-(2,3-Dichloro-phenyl)-[1,2,4]triazine-3,5-diamine(lamotrigine), GI 267119X; 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, Lamotrigine, United States Pharmacopeia (USP) Reference Standard, Lamotrigine, Pharmaceutical Secondary Standard; Certified Reference Material, Lamotrigine for peak identification, European Pharmacopoeia (EP) Reference Standard, Lamotrigine for system suitability, European Pharmacopoeia (EP) Reference Standard, Lamotrigine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Crisomet, lamitrin, lamotrigin, Lamictin (TN), Faes Brand of Lamotrigine, D03FLC, Juste Brand of Lamotrigine, Desitin Brand of Lamotrigine, Lamotrigine [USAN:BAN:INN], C9-H7-Cl2-N5, CID3878, Glaxo Wellcome Brand of Lamotrigine, GlaxoSmithKline Brand of Lamotrigine, CS-O-11675, C047781, D000077213, 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diyldiamine, Lamotrigine, 98%, a novel anticonvulsant drug for inhibition of 5-HT - 1G 1g, LTg,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited